首页> 外文期刊>中华医学杂志(英文版) >Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population
【24h】

Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population

机译:中国汉族人群烟酰胺腺嘌呤二核苷酸磷酸氧化酶亚基p22phox基因多态性减少与阻塞性睡眠呼吸暂停低通气综合征的关系

获取原文
获取原文并翻译 | 示例
       

摘要

Background Increased production of reactive oxygen species (ROS) is thought to play a major role in the pathogenesis of obstructive sleep apnea-hypopnea syndrome (OSAHS). The reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex is an important source of ROS. The p22phox subunit is polymorphic with a C242T variant that changes histidine-72 for a tyrosine in the potential heme binding site. This study aimed to investigate the relationship between NADPH oxidase subunit p22phox gene polymorphism and OSAHS. Methods The genotypes of p22phox polymorphism were determined by polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) assay in 176 unrelated subjects of the Han population in southern region of China (including 107 OSAHS subjects and 69 non-OSAHS subjects), while the plasma concentration of superoxide dismutase (SOD) was detected in the two groups, and p22phox mRNA expression in peripheral blood mononuclear cell (PBMC) was determined with reverse transcription polymerase chain reaction (RT-PCR).Results The phagocyte NADPH oxidase subunit p22phox mRNA expression was significantly increased in the OSAHS group than that in the non-OSAHS group (P<0.01). Compared with the non-OSAHS control group ((85.31±9.23) U/ml), the levels of SOD were lower in patients with OSAHS ((59.65±11.61) U/ml (P<0.01). There were significant differences in genotypes distribution in p22phox polymorphism between the two groups (P=0.02). Compared with the non-OSAHS control group, the OSAHS group had a significantly higher T allele frequency in p22phox polymorphism (P=0.03). There were independent effects of p22phox polymorphism on body mass index (BMI), neck circumference (NC), waist-to-hip ratio (WHR) in the OSAHS group, and the carriers of the T allele of p22phox polymorphism had greater NC, WHR, systolic blood pressure (SBP), diastolic blood pressure (DBP) and apnea-hypopnea index (AHI) (P <0.05), but the carriers of the T allele had lower SOD (P <0.01) and lowest SaO2 (P=0.04). There was no significant difference in p22phox mRNA expression between the OSAHS groups with or without T allele (P=0.45). Conclusions The NADPH oxidase subunit p22phox gene polymorphism may be associated with susceptibility to OSAHS, and it may be an important candidate gene for OSAHS.
机译:背景活性氧(ROS)的产生增加被认为在阻塞性睡眠呼吸暂停低通气综合症(OSAHS)的发病机理中起主要作用。还原的烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶复合物是ROS的重要来源。 p22phox亚基具有C242T变异体的多态性,该变异体在潜在的血红素结合位点改变了酪氨酸的组氨酸72。本研究旨在探讨NADPH氧化酶亚基p22phox基因多态性与OSAHS的关系。方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析方法确定中国南部地区176例汉族人群中p22phox基因多态性的基因型(包括107名OSAHS受试者和69名非OSAHS受试者),而结果两组均检测血浆超氧化物歧化酶(SOD)浓度,并通过逆转录聚合酶链反应(RT-PCR)检测外周血单个核细胞(PBMC)p22phox mRNA的表达。结果吞噬细胞NADPH氧化酶亚基p22phox mRNA OSAHS组的表达明显高于非OSAHS组(P <0.01)。与非OSAHS对照组相比(85.31±9.23)U / ml,OSAHS患者的SOD水平较低((59.65±11.61)U / ml(P <0.01)。两组之间p22phox多态性的分布(P = 0.02),与非OSAHS对照组相比,OSAHS组p22phox多态性的T等位基因频率明显更高(P = 0.03),p22phox多态性对p22phox多态性有独立影响。 OSAHS组的体重指数(BMI),颈围(NC),腰臀比(WHR)和p22phox多态性的T等位基因携带者的NC,WHR,收缩压(SBP)更高,舒张压(DBP)和呼吸暂停低通气指数(AHI)(P <0.05),但T等位基因携带者的SOD较低(P <0.01),SaO2最低(P = 0.04)。结论:NADPH氧化酶亚基p22phox基因polymorp在OSAHS组之间的差异均显着升高(P = 0.45)。组蛋白可能与OSAHS的易感性有关,它可能是OSAHS的重要候选基因。

著录项

  • 来源
    《中华医学杂志(英文版)》 |2009年第12期|1369-1374|共6页
  • 作者单位

    Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Key Laboratory of Respiratory Disease, Ministry of Health,Wuhan, Hubei 430030, China;

    Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Key Laboratory of Respiratory Disease, Ministry of Health,Wuhan, Hubei 430030, China;

    Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Key Laboratory of Respiratory Disease, Ministry of Health,Wuhan, Hubei 430030, China;

    Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Key Laboratory of Respiratory Disease, Ministry of Health,Wuhan, Hubei 430030, China;

  • 收录信息 中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 内科学;
  • 关键词

  • 入库时间 2022-08-19 04:00:03
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号